Ownership history in Larson Financial Group LLC · 9 quarters on record
This page tracks every 13F SEC filing in which Larson Financial Group LLC reported a position in GINKGO BIOWORKS HOLDINGS INC (DNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 181 | +175 | +2916.7% | 0.00% | $3K | $14.58 |
| 2025 Q2 | UNCHANGED | 6 | — | 0% | 0.00% | $68 | $11.25 |
| 2025 Q1 | UNCHANGED | 6 | — | 0% | 0.00% | $34 | $5.70 |
| 2024 Q4 | REDUCED | 6 | -75 | -92.6% | 0.00% | $59 | $9.82 |
| 2024 Q3 | REDUCED | 81 | -2,169 | -96.4% | 0.00% | $660 | $8.15 |
| 2024 Q2 | UNCHANGED | 2,250 | — | 0% | 0.00% | $752 | $13.36 |
| 2024 Q1 | UNCHANGED | 2,250 | — | 0% | 0.00% | $3K | $46.40 |
| 2023 Q4 | ADDED | 2,250 | +2,000 | +800.0% | 0.00% | $4K | $67.60 |
| 2023 Q3 | INITIATED | 250 | — | — | 0.00% | $453 | — |
As of 2025 Q4 — sorted by position size